Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
New Clinic Satisfaction Tool Provides Real-Time Feedback
THURSDAY, April 26, 2018 (HealthDay News) — A new clinic satisfaction tool improves communication and provides real-time feedback, according to a study published online April 14 in Neurosurgery.
Abstract/ Full Text (subscription or payment may be required)
Knowledge Not Tied to Addictive Tanning Behavior in Millennials
FRIDAY, April 27, 2018 (HealthDay News) — For millennials, sun protection knowledge is not associated with addictive tanning behavior, according to a recent study published in the Journal of Consumer Affairs.
Low-Dose Hyaluronidase Can Remove Hyaluronic Acid Fillers
THURSDAY, April 26, 2018 (HealthDay News) — Very low doses of hyaluronidase can remove hyaluronic acid filler nodules, but more rapid resolution is seen with slightly higher doses, according to a study published online April 25 in JAMA Dermatology.
Abstract/Full Text
Editorial (subscription or payment may be required)
Saturday Is National Prescription Drug Take Back Day
THURSDAY, April 26, 2017 (HealthDay News) — The U.S. Drug Enforcement Administration and local agencies are holding the 15th National Prescription Drug Take Back Day across the country this Saturday, April 28.
More Information
Find a Nearby Collection Site
Medicare Requiring Hospitals to Post Prices Online
WEDNESDAY, April 25, 2018 (HealthDay News) — U.S. hospitals will have to post their standard prices online and make it easier for patients to access their electronic medical records, Medicare officials said Tuesday.
Serlopitant Found to Be Safe, Effective for Chronic Pruritus
TUESDAY, April 24, 2018 (HealthDay News) — Serlopitant has potential as a therapy for the treatment of chronic pruritus, according to a study published in the May issue of the Journal of the American Academy of Dermatology.
Patients Prefer Doctors Who Engage in Face-to-Face Visits
MONDAY, April 23, 2018 (HealthDay News) — Patients prefer physicians who engage in face-to-face (F2F) clinic visits, rather than those using an examination room computer (ERC), according to a research letter published online April 19 in JAMA Oncology.
Abstract/Full Text (subscription or payment may be required)
Phone App Linked to Improved Psoriasis Treatment Adherence
MONDAY, April 23, 2018 (HealthDay News) — A smartphone app is associated with improved short-term adherence to a cutaneous foam treatment for psoriasis, according to a study published online April 14 in the British Journal of Dermatology.
Abstract/Full Text (subscription or payment may be required)
PAs May Have Lower Diagnostic Accuracy for Melanoma
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions 
Considerable Global Disparities Found in Access to Dermatological Care 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Psoriasis Linked to Impairment of Some Sleep Domains 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis 
Dose Reduction of Biologics Effective, Safe for Psoriasis .jpg)
